Journal of atherosclerosis and thrombosis
Cilostazol Contributes to Risk Reduction of Stroke Recurrence without Mediating a Reduction of Blood Pressure: Results from CSPS.com.
Kaori Miwa, Masatoshi Koga, Katsuhiro Omae, Naruhiko Kamogawa, Shinichiro Uchiyama, Shoki Hayami, Masatoshi Shoji, Haruhiko Hoshino, Kazumi Kimura, Kazuo Minematsu, Takenori Yamaguchi, Kazunori Toyoda, CSPS.com Trial Investigators
Published: 202510.5551/jat.65901
Abstract
AIM: Cilostazol, a phosphodiesterase III inhibitor, reduces the risk of stroke recurrence among patients with noncardioembolic ischemic stroke through inhibition of the platelet function and its pleiotropic effects. Its potential mechanisms include i…
Preview only. Read the full abstract at the source